Morgan Stanley, stocks

JP Morgan analyst Kian Abouhossein maintained a Neutral rating and boosted the price target from $100 to $104 on Dec. 6, 2024 ...
Morgan Stanley is a buy on weakness with strong dividend growth and projected revenue growth in Q4 2024 and early 2025. Click for our MS earnings preview.
Morgan Stanley initiated coverage of Palantir Technologies Inc. (NYSE:PLTR) with an underweight rating and $60 price target ...
Vistra stock was one of the biggest winners of 2024, and has already started 2025 on a positive note, rising nearly 19% in ...
The sale comes as a Morgan Stanley analyst cautioned that Palantir is “trading too far ahead” of its intrinsic value as it ...
The bulk of Morgan Stanley's new managing directors, or 46%, work for the investment bank.
Investing.com - Experian's (LON:EXPN) outlook for margin expansion is "robust" and underpins the potential for sustained ...